Across TCGA pan-cancer cohorts, SSR1P1 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated SSR1P1 data layer.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher SSR1P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SSR1P1 expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.
UCEC, CHOL, and ACC are the cancer types where SSR1P1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.